These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1829879)

  • 21. Trimethoprim-sulfamethoxazole plus amikacin versus ceftazidime monotherapy as empirical treatment in patients with neutropenia and fever.
    Engervall P; Günther G; Ljungman P; Lönnqvist B; Hast R; Stiernstedt G; Kalin M; Ringertz S; Bjökholm M
    Scand J Infect Dis; 1996; 28(3):297-303. PubMed ID: 8863366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of severe sepsis in bone marrow transplant recipients with teicoplanin in combination with beta-lactams and aminoglycosides.
    Fauser AA; Lang E; Dölken G; Bross KJ; Schmid J; Sörgel F
    Infection; 1991; 19(3):195-200. PubMed ID: 1832419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Teicoplanin in the treatment of gram-positive bacteraemia in neutropenic patients.
    Micozzi A; Venditti M; Amadori S; Pulsoni A; Tirindelli C; Martino P
    Br J Haematol; 1990 Dec; 76 Suppl 2():19-23. PubMed ID: 2149046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ceftazidime monotherapy is as effective as ceftazidime combined with gentamicin in the treatment of febrile neutropenic patients.
    Kinsey SE; Machin SJ; Goldstone AH
    J Hosp Infect; 1990 Apr; 15 Suppl A():49-53. PubMed ID: 1971645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Teicoplanin in empirical combined antibiotic therapy of bacteraemias in bone marrow transplant patients.
    Menichetti F; Del Favero A; Bucaneve G; Aversa F; Baldelli F; Felicini R; Terenzi A; Pauluzzi S
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():105-11. PubMed ID: 2965121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Monotherapy with meropenem in febrile granulocytopenic patients].
    Sanz MA; Jarque I; Larrea L
    Enferm Infecc Microbiol Clin; 1997 Sep; 15 Suppl 1():69-72. PubMed ID: 9410073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Piperacillin plus amikacin vs. piperacillin plus amikacin plus teicoplanin for empirical treatment of febrile episodes in neutropenic patients receiving quinolone prophylaxis.
    Martino P; Micozzi A; Gentile G; Raccah R; Girmenia C; Mandelli F
    Clin Infect Dis; 1992 Aug; 15(2):290-4. PubMed ID: 1387806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. The Intercontinental Antimicrobial Study Group.
    De Pauw BE; Deresinski SC; Feld R; Lane-Allman EF; Donnelly JP
    Ann Intern Med; 1994 May; 120(10):834-44. PubMed ID: 8154643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients.
    Behre G; Link H; Maschmeyer G; Meyer P; Paaz U; Wilhelm M; Hiddemann W
    Ann Hematol; 1998 Feb; 76(2):73-80. PubMed ID: 9540761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized clinical trial of ceftriaxone and teicoplanin versus ceftazidime and teicoplanin as antibiotic therapy in febrile neutropenic cancer patients and bone marrow transplant recipients.
    Fauser AA; Lang E; Köchling G; Daschner FD
    Infection; 1994; 22(4):271-5. PubMed ID: 8002087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicenter, randomized trial of ciprofloxacin plus azlocillin versus ceftazidime plus amikacin for empiric treatment of febrile neutropenic patients.
    Flaherty JP; Waitley D; Edlin B; George D; Arnow P; O'Keefe P; Weinstein RA
    Am J Med; 1989 Nov; 87(5A):278S-282S. PubMed ID: 2686429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients.
    Hess U; Böhme C; Rey K; Senn HJ
    Support Care Cancer; 1998 Jul; 6(4):402-9. PubMed ID: 9695210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The use of teicoplanin in neutropenic patients: values and limits].
    Espinouse D; Chomarat M
    Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):552-6. PubMed ID: 2143573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Combination of a 3d-generation cephalosporin (cefotaxime or ceftazidime) and a new quinolone (pefloxacine) in the treatment of febrile episodes in neutropenic diseases (37 cases)].
    Guy H; Caillot D; Solary E; Bielefeld P; Portier H; Kazmierczak A
    Presse Med; 1987 Dec; 16(43):2172-5. PubMed ID: 2963306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia.
    ; Calandra T; Klastersky J; Gaya H; Glauser MP; Meunier F; Zinner SH
    N Engl J Med; 1987 Dec; 317(27):1692-8. PubMed ID: 2892130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Imipenem/cilastatin versus ceftazidime-amikacin in the treatment of febrile neutropenic patients].
    Pérez C; Sirham M; Labarca J; Grebe G; Lira P; Oliva J; Duhalde M; Ocqueteau M; Acuña G
    Rev Med Chil; 1995 Mar; 123(3):312-20. PubMed ID: 8525170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ceftazidime with or without vancomycin vs. cephalothin, carbenicillin and gentamicin as the initial therapy of the febrile neutropenic pediatric cancer patient.
    Granowetter L; Wells H; Lange BJ
    Pediatr Infect Dis J; 1988 Mar; 7(3):165-70. PubMed ID: 3282214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective, randomized comparison of ceftazidime and ciprofloxacin as initial empiric therapy in neutropenic patients with fever.
    Bayston KF; Want S; Cohen J
    Am J Med; 1989 Nov; 87(5A):269S-273S. PubMed ID: 2686428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ceftazidime plus amikacin plus teicoplanin or vancomycin in the empirical antibiotic therapy in febrile neutropenic cancer patients.
    Nucci M; Biasoli I; Braggio S; Portugal R; Schaffel R; Maiolino A; Loureiro MM; Spector N; Pulcheri W
    Oncol Rep; 1998; 5(5):1205-9. PubMed ID: 9683836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double-blind trial.
    Feld R; DePauw B; Berman S; Keating A; Ho W
    J Clin Oncol; 2000 Nov; 18(21):3690-8. PubMed ID: 11054442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.